Newrite Medical completed a 1 billion yuan Series E financing.

36Kr learned that, according to Shanghai Science and Technology Innovation Group, recently, "Newrite Medical" successfully completed a Series E financing of RMB 1 billion. This round of financing was co-led by Shanghai Science and Technology Innovation Group under Shanghai State-owned Investment Corporation, together with Shanghai Guoxin and existing shareholder Nanjing Gaoke Xinjun. Multiple institutions such as the intellectual property fund under Shanghai Science and Technology Innovation Group, Dingtaixing, Zhongqi Capital, Yuekai Capital, Lingang Lanwan, Guoke Investment, Shiyao Guofang, Cornerstone Capital, Sichuan Venture Capital, Pudong Venture Capital, and Yifeng Capital participated in the follow-on investment.